bullish

# 33 India Insight: Paytm Collaborates with Axis, Gland Pharma Approval, Tata Consumer Right Issue

203 Views24 Jul 2024 20:05
​Paytm and Axis Bank team up for improved POS solutions, Gland Pharma and Zydus Lifesciences receive USFDA nods, Tata Consumer plans Rs 3,000 crore rights issue for financial boost.
What is covered in the Full Insight:
  • Paytm and Axis Bank Collaboration
  • Gland Pharma and Zydus Lifesciences USFDA Approvals
  • Tata Consumer Rights Issue
  • India's Aircraft and Ship Leasing Initiative
  • SpiceJet's Fundraising Efforts
SUMMARY
(Sign Up to Access)
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
  • Unlock all research summaries
  • Follow top, independent analysts
  • Receive personalised alerts and emails
  • Access Briefings, Analytics, and Events

Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.

Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 4-minute read)
Discussions
(Paid Plans Only)
chart-bar
Logo
Top Quartile
Sudarshan Bhandari
India Equity Analyst - Fundamental & Thematic
Beat the Street
Equity Bottom-UpThematic (Sector/Industry)
x